Cargando…
Two cases of ceftriaxone‐induced encephalopathy treated by hemoperfusion in hemodialysis patients
Ceftriaxone is a third‐generation cephalosporin commonly used to treat infection. However, encephalopathy is an emerging adverse effect of ceftriaxone infusion. These patients present with various symptoms, including those of neurotoxicity, that typically resolve 1 week after discontinuation of ceft...
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley & Sons, Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9545014/ https://www.ncbi.nlm.nih.gov/pubmed/35441472 http://dx.doi.org/10.1111/hdi.13018 |